Switch to fixed-dose ainuovirine, lamivudine, and tenofovir DF versus elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed people living with HIV-1: the 48-week results of the SPRINT trial, a multi-centre, randomised, double-blind, active-controlled, phase 3, non-inferiority trial
Titel:
Switch to fixed-dose ainuovirine, lamivudine, and tenofovir DF versus elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed people living with HIV-1: the 48-week results of the SPRINT trial, a multi-centre, randomised, double-blind, active-controlled, phase 3, non-inferiority trial
Auteur:
Zhang, Fujie Wu, Hao Cai, Weiping Ma, Ping Zhao, Qingxia Wei, Hongxia Lu, Hongzhou Wang, Hui He, Shenghua Chen, Zhu Chen, Yaokai Wang, Min Wan, Wan Fu, Heliang Qin, Hong